Effect of dopamine D2/D3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine

By Jaworski J.N.   Gonzales R.A.   Randall P.K.  

European Journal of Pharmacology, Vol. 418, Iss. 3, 2001-04 ,pp. : 201-206

Elsevier

Access to resources Recommend Favorite

Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D_2/3 receptor antagonist sulpiride

By Pezze Marie   Dalley Jeffrey   Robbins Trevor  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 307-313

Springer Publishing Company

Access to resources Recommend Favorite

Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D₂ receptor mediated phenomenon?

By Qiao Jing   Gao Jun   Shu Qing   Zhang Qinglin   Hu Gang   Li Ming  

Psychopharmacology, Vol. 231, Iss. 8, 2014-04 ,pp. : 1649-1659

Springer Publishing Company

Access to resources Recommend Favorite

The role of endogenous opioids in the luteinizing hormone surge in rats: studies with clocinnamox, a long-lasting opioid receptor antagonist

By Lieberman P.B.   Woods J.H.   Young E.A.  

European Journal of Pharmacology, Vol. 352, Iss. 1, 1998-07 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonist

By Tanaka T.   Fukuta Y.   Higashino R.   Sato R.   Nomura Y.   Fukuda Y.   Ito S.   Takei M.   Kurimoto T.   Tamaki H.  

European Journal of Pharmacology, Vol. 357, Iss. 1, 1998-09 ,pp. : 53-60

Elsevier

Access to resources Recommend Favorite